Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review.
Sign Up to like & getrecommendations! Published in 2021 at "Advances in medical sciences"
DOI: 10.1016/j.advms.2021.07.005
Abstract: BACKGROUND Patients with Eastern Cooperative Oncology Group Performance Status 2 (ECOG PS 2) are not included in most randomized clinical trials and registry studies. Nevertheless, immune checkpoint inhibitors are registered in the USA and Europe… read more here.
Keywords: immunotherapy; state knowledge; ecog; current state ... See more keywords